VRDN-001, a full antagonist antibody to IGF-1 receptor: in vitro pharmacology and phase 1/2 results in patients with thyroid eye disease (TED)

Raymond Douglas, Roger Turbin + Show 12 more

https://doi.org/10.1530/endoabs.92.op-09-01

Copy DOI

Publication Date: Aug 24, 2023

Abstract

VRDN-001, a full antagonist antibody to IGF-1 receptor: <i>in vitro</i> pharmacology and phase 1/2 results in patients with thyroid eye disease (TED)

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author